Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

AdViTA COULD HAVE SIGNED A COLLABORATION AGREEMENT, HAVE RELIEF FUND THEM AND THEN INFRINGE ON THEIR PATENT, NO???

In April, Relief and AdVita initiated an investigator-sponsored phase 2 trial with inhaled aviptadil for the prevention of Covid-related acute respiratory distress syndrome. The study, “Inhaled aviptadil for the Prevention of Covid-19 Related ARDS” (NCT 04536350), is a randomised, double-blind, placebo-controlled phase 2 trial being conducted at major clinical sites in Switzerland.

http://www.privateequitywire.co.uk/2021/07/28/304200/relief-acquire-all-outstanding-shares-advita

LETS HELP OURSELVES WITH SOMEONE ELSES PROPERTY, A RECIPE FOR POVERTY…???